Validation of the Occupational Sitting and Physical Activity Questionnaire for E-Sports Players

June 5, 2023 updated by: Nilay Arman, Istanbul University - Cerrahpasa (IUC)
Electronic sports (Esports) has become a branch that started to gain popularity in the gaming community in the early 2000s and that more and more individuals are interested in. Esports players are often called sedentary athletes because gaming requires prolonged sedentary activity. The aim of this study is to adapt the Occupational Sitting and Physical Activity Questionnaire to individuals playing Esports and to validate it in Turkish.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Electronic sports (Esports) has become a branch that started to gain popularity in the gaming community in the early 2000s and that more and more individuals are interested in. Esports players are often called sedentary athletes because gaming requires prolonged sedentary activity. Although studies have examined the physical activity levels of Esports players with questionnaires, they emphasize that the results may be more variable because they do not control for potential confounding factors such as gender, age, game type, and performance level. Among the questionnaires used in the studies, there was no study evaluating the player-specific physical activity level. Therefore, the aim of this study is to validate the Occupational Sitting and Physical Activity Questionnaire in individuals playing Esports. Individuals aged 12-24, who play computer games 3-4 times a week for 2-4 hours professionally or 7-14 hours a week as an amateur, and have the ability to read and understand Turkish will be included in the study. Individuals with severe physical limitations that prevent physical activity and individuals with cognitive impairment will be excluded from the study. Correlation of the scale with Visual Analogue Scale (VAS), International Physical Activity Questionnaire-Short Form for construct validity, Young Internet Addiction Test-Short Form (YİBT-SF) and Buss-Perry Aggression Scale will be tested, respectively. In order to determine the test-retest reliability of the Turkish version of the scale, individuals will be asked to fill in the scale again 7-14 days after they first filled out the scale.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey
        • Istanbul University-Cerrahpaşa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Esports and amateur recreational players between the ages of 12-24 who agree to voluntarily participate in the study will be included.

Description

Inclusion Criteria:

ESports Players:

  • Volunteer to participate in the study
  • Age between of 12-24
  • Training for 2-4 hours 3-4 times a week
  • Playing e-sports for at least 1 year
  • Play and be licensed as an active esports player in an official esports tournament or league

Amateur Recreational players:

  • Not having an e-athlete license
  • Age between of 12-24
  • Playing games 7-14 hours a week
  • Have an active game account in any region

Exclusion Criteria:

ESports Players:

  • Having had a head injury accident within the last week
  • No e-sports license
  • Having a congenital disease or deformity
  • Having a diagnosis of psychiatric and neurological disease
  • Having a diagnosis of musculoskeletal disease

Amateur Recreational players:

  • Having a systemic or congenital disease
  • Having a diagnosis of neurological and psychiatric disease
  • Having a disorder that affects the musculoskeletal system

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Occupational Sitting and Physical Activity Questionnaire (OSPAQ)
Time Frame: Baseline (First assessment)
Occupational Sitting and Physical Activity Questionnaire; It is a short scale that records the proportion of working time spent sitting, standing, walking, and doing heavy work, and the total time worked in the last five working days. Participants will be asked to indicate the percentage of time they spend on these activities in a day. All percentages specified by participants for sitting, standing, walking and heavy work activities will be added up.
Baseline (First assessment)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Occupational Sitting and Physical Activity Questionnaire (OSPAQ)
Time Frame: Within a 7-to-14-day period after the first assessment (Second assessment)
Occupational Sitting and Physical Activity Questionnaire; It is a short scale that records the proportion of working time spent sitting, standing, walking, and doing heavy work, and the total time worked in the last five working days. Participants will be asked to indicate the percentage of time they spend on these activities in a day. All percentages specified by participants for sitting, standing, walking and heavy work activities will be added up.
Within a 7-to-14-day period after the first assessment (Second assessment)
International Physical Activity Questionnaire-Short Form (IPAQ-Short Form)
Time Frame: Baseline (First assessment)
IPAQ was developed to measure the health and physical activity levels of the society. This global scale allows the assessment of physical activity. The short version provides information about the time spent walking, moderate and vigorous activities, and sedentary activities. Outcome evaluation is carried out by reporting weekly activity duration with an estimation of MET energy expenditure for each activity category.
Baseline (First assessment)
Visual Analogue Scale (VAS)
Time Frame: Baseline (First assessment)
The VAS is a pain assessment scale using a 10 cm line graded as "no pain" 0 points and "worst pain imaginable" 10 points.
Baseline (First assessment)
Young Internet Addiction Test-Short Form (YİBT-SF)
Time Frame: Baseline (First assessment)
The YİBT-SF, which measures internet addiction, consists of 12 items and is a five-point Likert scale (1=Never, 5=Very often).
Baseline (First assessment)
Buss-Perry Aggression Questionnaire
Time Frame: Baseline (First assessment)
It is an aggression assessment scale consisting of 34 items. The situations described in the items question five sub-forms of aggression (physical aggression, verbal aggression, anger, hostility, and indirect aggression). It is a five-point Likert-type self-rating scale.
Baseline (First assessment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Istanbul University - Cerrahpasa (IUC)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2023

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 1, 2023

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 1, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 5, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 5, 2023

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 13, 2023

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 13, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 5, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • IstanbulUC2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings